Publications
P302
Inorg. Chem., 2025, 64, 16192-16203.
Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold.
P301
J. Med. Mycol. 2025, 101583.
A One Health Perspective on Diutina catenulata: Phenotypic Traits, Stress Sensitivity, and Virulence Across Diverse Isolates.
P278
Antimicrob. Agents Chemother. 2024, e0002224.
Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.
P246
Microorganisms. 2022, 10, 104.
Impact of TR34/L98H, TR46/Y121F/T289A and TR53 alterations in azole‐resistant Aspergillus fumigatus on sterol composition and modifications after In Vitro exposure to itraconazole and voriconazole.
P215
Sci. Rep. 2020, 10, 6211.
In vitro immune responses of human PBMCs against Candida albicans reveals fungal and leucocyte phenotypes associated with fungal persistence.
doi: 10.1038/s41598-020-63344-6
P194
Hum. Immunol. 2019, 80, 999-1005.
Double positive CD4+CD8+ T cells are part of the adaptive immune response against Candida albicans.
doi: 10.1016/j.humimm.2019.09.008
P161
Infect. Immun. 2017, 85, e00807-16;
Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes During Granuloma-like Formation.
doi: 10.1128/IAI.00807-16.
P105
PLoS ONE, 2012, 7(6), e40185, 1-13.
First Human Model of In Vitro Candida albicans Persistence within Granuloma for the Reliable Study of Host-Fungi Interactions.